Comparative pharmacognostic and phytochemical investigation of two plant species valued as medhya rasayanas.

Centella asiatica and Bacopa monnieri widely known as Brahmi are considered as ‘Medhya rasayanas’ in Ayurveda meaning brain tonic. However, these plants are distinctly different. The name Brahmi, Jala-brahmi or water-brahmi is assigned to Bacopa monnieri whereas "mandukaparni", often confused with Brahmi, refers to Centella asiatica. A detailed investigation of whole plant and roots of both the crude drugs was carried out. The diagnostic characteristics includes presence of stomata, vessels with spiral thickening, rosette crystals of calcium oxalate in Centella asiatica and xylem vessels with reticulate thickening, glandular hairs, simple, round and oval starch grains, measuring 4-14 μ in diameter in Bacopa monnieri. Various physicochemical parameters were also established. Phytochemical screening revealed the presence of many therapeutically important classes of phytoconstituents such as glycosides, alkaloids, saponins, protiens and carbohydrates. The present work was undertaken to generate information regarding relevant pharmacognostical, phytochemical and physicochemical data needed for proper identification and authentification of two crude drugs belonging to two different families, mainly focusing and exploring the aspects leading to common effect of improving memory.

Antiulcer activity and the mechanism of action of magaldrate in gastric ulceration models of rat.

The present study was undertaken to investigate the mechanism of cytoprotective effects of magaldrate in aspirin plus pylorus-ligation model and ethanol-induced gastric ulcer model in rats. Magaldrate (60 mg/kg, p.o.) produced a significant reduction in the ulcer index and significant increase in mucus content in ethanol-induced gastric ulceration in rats. In aspirin plus pylorus-ligation model magaldrate produced significant decrease in ulcer index, total acidity and protein content (PR). It did not produce any significant change in volume of gastric secretion. However, it produced significant increase in total carbohydrate (TC) level but not in ratio between TC and proteins. It also produced a significant decrease in lipid peroxidation (as expressed by thiobarbituric acid reactive substance). Our data suggests the cytoprotective action of magaldrate on gastric mucosal cells which may be due to protection of gastric mucosa from lipid peroxidation.

Effect of chronic treatment with spirapril on biochemical parameters in streptozotocin-diabetic and spontaneously hypertensive rats.

Present investigation was undertaken to study the effects of 6 week treatment with spirapril (2 mg/kg po) on insulin sensitivity, and serum lipid levels in streptozotocin (STZ)-diabetic and spontaneously hypertensive (SH) rats. Treatment of rats with spirapril in diabetic and diabetic with hypertensive animals significantly prevented STZ-induced loss of body weight, hypertension, and bradycardia. It also partially but significantly prevented STZ-induced hyperglycaemia in both diabetic Wistar and SH animals. Insulin level was not altered by spirapril treatment. There was significant reduction in cholesterol levels in the diabetic rats. In conclusion, the present investigation presents a number of beneficial effects of spirapril treatment in diabetic and/or hypertensive rats. Spirapril may be considered as one of the drugs of choice in treatment of hypertension when associated with diabetes

Investigation into the possible mechanisms involved in altered digoxin levels in diabetic patients.

The present study was undertaken to investigate the possible factors which may contribute to the altered digoxin levels in diabetic patients. The digoxin levels were found to be significantly higher in diabetics (1.74 +/- 0.09 ng/ml) as compared to non-diabetics (0.76 +/- 0.07 ng /ml). There was a positive correlation between digoxin levels and glycosylated haemoglobin levels. All diabetic patients had serum creatinine, urea and potassium levels within normal limits. However, serum TSH levels were found to be significantly higher in diabetics as compared to controls. Serum tri-iodo-1-thyronine (T3) levels were found to be lower in diabetics as compared to non-diabetics. Our data suggests that diabetes-mellitus causes alteration of digoxin levels. One of the causes of this increase in digoxin levels may be a tendency towards mild hypothyroidism associated with diabetes mellitus.